01.09.2010MORE THAN 100 EMERGING MEDTECH COMPANIES VIE TO PARTICIPATE IN SEPTEMBER MEDTECH SUMMIT IN LAUSANNEYou are hereNewsMORE THAN 100 EMERGING MEDTECH COMPANIES VIE TO PARTICIPATE IN SEPTEMBER MEDTECH SUMMIT IN LAUSANNE
Finalists to present their companies to venture capital and investment firms representing €10 billion in investment funding
Lausanne, Switzerland, August 24, 2010 – The European Tech Tour Association today announced that more than 100 early and later growth stage Medtech companies are vying to participate in the 2nd Medtech Summit to be held in Lausanne on September 29-30. During the event, 25 selected companies will have an opportunity to present their technologies to industry players and representatives from leading cross-border venture capital and global investment firms representing more than €10 billion in investment capital.
“We expect the 2010 Medtech Summit to generate funding opportunities for participating companies,” said Bill Muirhead, President of the 2010 Medtech Summit and Chairman and co-founder of biotech company, Ayanda Biosystems. “At the last event, after the Summit Selection Committee selected CoreValve, a cardiovascular device company, as the Medtech Innovation award winner at the Entrepreneur of the Year ceremony, Medtronic acquired it a few months later for US 0+ million. Several other participants also went on to secure funding for further growth and expansion.”
This year, Medtech applicants represent 17 European countries and 12 different Medtech industry segments. Finalists will be selected by a panel of European Medtech experts and venture capital and investment firms in early September.
Antoine Papiernik, Managing Partner at Sofinnova Partners, commented: “The Medtech Summit is a key forum for identifying the best emerging European Medtech technologies and providing the investment capital to bring these technologies to market. The 2010 event is particularly important because it comes in the wake of the recent economic crisis. Participation in this event can help promising Medtech companies find the financial resources that are hard to secure in this climate.”
Steve Oesterle, the Senior Vice President for Medicine and Technology from Medtronic, the gold sponsor for the event, will deliver the keynote speech, which will also feature a visit to their world-class medical manufacturing facility in Tolochenaz, Switzerland. Other participating sponsors include Sofinnova, Morgan Lewis, Swiss Medtech, Canton de Vaud, Credit Suisse, Entrepreneurs Fund, NeoMed and Valtronic Technologies.
Although applications to present at the 2010 Medtech Summit have now closed, spaces are still available for delegates. For more information and to register, please see: http://www.techtour.com/med2010/Overview.htm
Laurian Harry Lukasz M. Bochenek
European Tech Tour Genevensis Healthcare Communications
+41 22 544 60 62 +41 22 365 99 51